Jessica L. Taylor, MD

Assistant Professor, Medicine

Jessica Taylor
617.414.7399
801 Massachusetts Ave Crosstown Center

Biography

Jessica L. Taylor, MD is an Assistant Professor of Medicine in General Internal Medicine at the Chobanian and Avedisian School of Medicine and Boston Medical Center and a board-certified Addiction Specialist. She attended Mount Sinai School of Medicine and completed internal medicine residency training at Beth Israel Deaconess Medical Center and Harvard Medical School, where she also served as a Chief Resident. Dr. Taylor’s clinical work focuses on the care of patients with substance use disorders, HIV, and viral hepatitis.

Her research interests include HIV prevention among people who inject drugs, HIV pre-exposure prophylaxis (PrEP) implementation, low-barrier substance use disorder treatment models, and overdose prevention. She is Co-Director of the Care Continuum Core for the Massachusetts site of the NIDA-funded Healing Communities Study, which aims to reduce fatal opioid overdose by 40%.

Dr. Taylor is the Medical Director of Faster Paths to Treatment, Boston Medical Center’s innovative, low-barrier substance use disorder bridge clinic and the Medical Director of the Transitional Care Clinic, a bridge clinic co-located with a low-threshold, transitional housing program for people experiencing homelessness. She directs HIV Prevention Programs at BMC. Her educational roles include directing the HIV Pathway for internal medicine residents and serving as core faculty in BUSM’s Addiction Medicine fellowship program.

Other Positions

  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine

Education

  • Mount Sinai School of Medicine, MD
  • Duke University, BS

Publications

  • Published on 2/16/2024

    Lewis NM, Smeltzer RP, Baker TJ, Sahovey AC, Baez J, Hensel E, Poole B, Stewart C, Cogan AG, Bullard M, Taylor JL. Feasibility of paying people who use drugs cash to distribute naloxone within their networks. Harm Reduct J. 2024 Feb 16; 21(1):42. PMID: 38365734.

    Read at: PubMed
  • Published on 2/8/2024

    Shahlapour M, Singh S, Christine PJ, Laks J, Evans J, Farrell NM, Khan GK, Taylor JL, Rozansky H. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic. J Addict Med. 2024 Feb 08. PMID: 38329815.

    Read at: PubMed
  • Published on 1/16/2024

    Taylor JL, Lasser KE. Intranasal Naloxone for Opioid Overdose. JAMA. 2024 Jan 16; 331(3):250-251. PMID: 38127361.

    Read at: PubMed
  • Published on 12/19/2023

    Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A, Kinnard EN, McAlearney AS, Bosak J, Medley B, Pinkhover A, Taylor JL, Samet JH, Lunze K. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions. J Subst Use Addict Treat. 2023 Dec 19; 159:209272. PMID: 38128649.

    Read at: PubMed
  • Published on 10/26/2023

    Komaromy M, Stone A, Peterson A, Gott J, Koenig R, Taylor JL. Facilitating exit from encampments: combining low-barrier transitional housing with stabilizing treatment for substance related problems. Addict Sci Clin Pract. 2023 Oct 26; 18(1):66. PMID: 37884986.

    Read at: PubMed
  • Published on 7/18/2023

    Rawlins-Pilgrim S, Wheelock A, Streed CG, Higham M, Krakower DS, Taylor JL. Survey assessment of HIV pre-exposure prophylaxis availability in student health services in New England colleges and universities. J Am Coll Health. 2023 Jul 18; 1-4. PMID: 37463515.

    Read at: PubMed
  • Published on 4/14/2023

    Taylor JL, Wakeman SE, Walley AY, Kehoe LG. Substance use disorder bridge clinics: models, evidence, and future directions. Addict Sci Clin Pract. 2023 Apr 14; 18(1):23. PMID: 37055851.

    Read at: PubMed
  • Published on 4/5/2023

    Martin AK, Perryman T, Bernstein JA, Taylor JL, Cruz R, Muroff J, Samet JH, Assoumou SA. Peer recovery coaching for comprehensive HIV, hepatitis C, and opioid use disorder management: The CHORUS pilot study. Drug Alcohol Depend Rep. 2023 Jun; 7:100156. PMID: 37113387.

    Read at: PubMed
  • Published on 3/24/2023

    Lescure TN, Stewart J, Sperring H, Ruiz-Mercado G, Taylor JL. Impact of COVID-19 on Sexually Transmitted Infection and HIV Screening at an Urban Safety-Net Hospital. AIDS Patient Care STDS. 2023 Mar 24. PMID: 36961407.

    Read at: PubMed
  • Published on 3/24/2023

    Lescure TN, Stewart J, Sperring H, Ruiz-Mercado G, Taylor JL. Impact of COVID-19 on Sexually Transmitted Infection and HIV Screening at an Urban Safety-Net Hospital. AIDS Patient Care STDS. 2023 Apr; 37(4):199-204. PMID: 36961407.

    Read at: PubMed

View 28 more publications: View full profile at BUMC

View all profiles